Le marché des dispositifs pulmonaires était évalué à 18 598,56 millions de dollars US en 2019 et devrait atteindre 39 965,01 millions de dollars US d'ici 2027 ; il devrait croître à un TCAC de 10,1 % de 2020 à 2027.
Les appareils pulmonaires ou respiratoires sont utilisés pour éliminer le mucus et les sécrétions des voies respiratoires ou des voies respiratoires. Ces dispositifs médicaux sont axés sur le diagnostic, le contrôle, le traitement, la gestion et l'évaluation des problèmes associés aux voies respiratoires. La croissance du marché des dispositifs pulmonaires est principalement attribuée au nombre croissant de cas de COVID-19 dans le monde et à la prévalence croissante des maladies respiratoires. De plus, les activités stratégiques des fabricants telles que l'innovation de type, les lancements de type et les approbations, ainsi que les investissements en R&D pour les progrès des ventilateurs devraient en outre favoriser la croissance du marché au cours de la période de prévision. Cependant, un scénario de remboursement défavorable limite la croissance du marché.
L'impact de la crise du COVID-19 devrait encore accélérer la croissance du marché des appareils respiratoires en Europe. Par exemple, Apex Medical se concentre sur la fourniture de solutions de ventilateur CPAP comme alternative de traitement COVID-19 selon l'Agence britannique de réglementation des médicaments et des produits médicaux (MHRA) aux patients souffrant d'insuffisance respiratoire. De plus, au Royaume-Uni (Royaume-Uni), par exemple, le gouvernement a demandé aux constructeurs automobiles, dont Ford, Honda et Rolls-Royce, de déplacer temporairement une partie de leur chaîne de montage des voitures vers le développement d'équipements respiratoires.
Régions lucratives pour le marché des dispositifs pulmonaires
Aperçu du marché
Le nombre croissant de cas de COVID-19 stimule la croissance du marché des dispositifs pulmonaires
Les maladies respiratoires infectieuses stimulent directement la demande de se soucier. La COVID-19 est la plus récente et la plus importante de ces maladies ; la pandémie a entraîné une augmentation de la demande d'équipements de protection individuelle et de ventilateurs, entre autres. La demande de ventilateurs a également augmenté en raison de l'épidémie de COVID-19, ce qui a entraîné un soutien gouvernemental et industriel pour accélérer le rythme de fabrication. À ce jour, le virus a infecté plus d'un quart de million de personnes dans le monde. Avec la propagation continue de ce virus, qui peut provoquer une pneumonie et des difficultés respiratoires, les hôpitaux sont confrontés à un approvisionnement limité en ventilateurs. Par exemple, en Italie, les hôpitaux ont été submergés de patients souffrant d'insuffisance respiratoire et le personnel médical doit prendre des décisions difficiles de vie ou de mort concernant les patients qui reçoivent des ventilateurs. Alors que la pénurie et la prévalence des maladies respiratoires augmentent, le marché mondial des dispositifs pulmonaires devrait croître à un rythme soutenu.
Pour l'instant, l'impact de la crise du COVID-19 devrait encore accélérer la croissance du marché des appareils respiratoires. En outre, la menace aura un impact durable sur les gouvernements et les agences de réglementation en termes de préparation future à la prochaine pandémie. Aujourd'hui, les gouvernements du monde entier rattrapent leur retard, intervenant rapidement pour tenter de créer des alliances avec les fabricants pour gérer la menace COVID-19. Et les agences de réglementation internationales envisagent d'accélérer l'approbation de certains appareils respiratoires.
Type-BasedInsights
Selon le type, le marché des appareils pulmonaires est segmenté en appareils thérapeutiques, consommables et accessoires, diagnostic dispositifs et dispositifs de surveillance. Le segment des dispositifs thérapeutiques détenait la plus grande part du marché en 2019. Cependant, le segment des consommables et accessoires devrait enregistrer le TCAC le plus élevé au cours de la période de prévision. Les dispositifs thérapeutiques pour les maladies pulmonaires comprennent des systèmes respiratoires autonomes très avancés tels que des appareils à pression positive des voies respiratoires, des ventilateurs, des concentrateurs d'oxygène, jusqu'à des dispositifs plus petits à usage régulier des patients tels que des concentrateurs d'oxygène portables, des inhalateurs, des nébuliseurs, des humidificateurs, des hottes à oxygène et des pompes.
Marché des appareils pulmonaires, par type - 2019 et 2027
Informations basées sur les applications
Sur la base des applications, le marché des appareils pulmonaires est segmenté en BPCO, asthme, apnée du sommeil, maladies infectieuses maladie et autres. Le segment de la MPOC détenait la plus grande part du marché en 2019. En outre, le même segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision. Trouble pulmonaire obstructif chronique communément appelé, car la MPOC est un groupe de troubles pulmonaires progressifs qui comprennent généralement la bronchite et l'emphysème. Les personnes atteintes de MPOC souffrent généralement des deux maladies. Fumer du tabac est connu pour être la principale cause de MPOC. De plus, l'exposition à long terme des individus à des irritants chimiques peut également entraîner la MPOC. La maladie prend généralement beaucoup de temps à se développer et à s'établir.
Informations basées sur l'utilisateur final
En fonction de l'utilisateur final, le marché des dispositifs pulmonaires est segmenté en hôpitaux, établissements de soins à domicile et soins ambulatoires centres. Le segment des hôpitaux détenait la plus grande part de marché en 2019 ; Cependant, on estime que le segment des établissements de soins à domicile enregistre le TCAC le plus élevé au cours de la période de prévision. On estime que le segment des hôpitaux détient une part considérable, car la majorité des patients des pays émergents et développés préfèrent se rendre dans les hôpitaux pour tout type de problème lié à la santé. De plus, le nombre croissant d'hôpitaux et l'adoption de plates-formes de diagnostic avancées offrent des opportunités lucratives pour la croissance du marché du segment hospitalier.
Insights stratégiques
Lancements de produits, fusions et acquisitions, collaborations , et les expansions sont les stratégies couramment adoptées par diverses entreprises pour étendre leur présence dans le monde et répondre à la demande croissante en élargissant leurs portefeuilles de produits respectifs. nom de marque dans le monde.
Marché des appareils pulmonaires par type
- Appareils thérapeutiques
- Consommables et accessoires
- Appareils de diagnostic
- Appareils de surveillance
Marché des appareils pulmonaires - par application
- Maladie pulmonaire obstructive chronique (MPOC)
- Apnée du sommeil< /li>
- Asthme
- Maladies infectieuses
- Autres
Marché des appareils pulmonaires - par utilisateur final
- Paramètres de soins à domicile
- Centres de soins ambulatoires
< li>Hôpitaux
Marché des appareils pulmonaires - par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite< /li>
- EAU
- Reste de la MEA
- Amérique du Sud et centrale (SCAM)
- Brésil
- Argentine
- Reste de SCAM
Profils des entreprises
- Koninklijke Philips NV
- Caire Inc. (Chart Industries)
- Inogen Inc.
- Invacare Corporation
- O2 Concepts
- Nidek Medical Types , Inc.
- Drive DeVilbiss International
- GCE Group
- Besco Medical
- Inova labs Inc. (ResMed)
< /ul>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.
The factors that are driving growth of the market are rising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. Moreover, Strategic activities by the manufacturerssuch as type innovation, type launches, and approvals, as well as R&D investment for advancements in ventilatorsare offering lucrative opportunities for the growth of the market.
The pulmonary devicesmarket majorly consists of the players such as Koninklijke Philips N.V, Caire Inc. (Chart Industries), Inogen Inc., Invacare Corporation, O2 Concepts, Nidek Medical Types, Inc., Drive DeVilbiss International, GCE Group, Besco Medical, and Inova labs Inc. (ResMed)amongst others.
The List of Companies - Pulmonary Devices Market
- Koninklijke Philips N.V.
- Caire Inc. (Chart Industries)
- Inogen Inc.
- Invacare Corporation
- O2 Concepts
- Nidek Medical Types, Inc.
- Drive DeVilbiss International
- GCE Group
- Besco Medical
- Inova labs Inc. (ResMed)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)